Introduction: Vitiligo is an acquired depigmenting skin disorder adversely affecting the
patient's quality of life. Despite the presence of several treatment modalities, ranging from …

Vitiligo is a cutaneous illness caused by melanocyte destruction or damage, resulting in
reduced or absent pigmentation of the skin, hair, and/or mucous membranes. Vitiligo affects …

Childhood vitiligo differs from adult vitiligo in many clinical parameters. The objective of the
current study was to study the clinicoepidemiologic profile of childhood vitiligo and to …

Background/objectives Individuals with vitiligo have an increased risk of depression, anxiety,
social isolation and detrimental effects on body image/self-esteem. However, assessments …

This study aims to assess the impact of childhood vitiligo on the psychological status and
quality of life of their parents, and to determine how this varies according to their children's …

Background: Vitiligo is a depigmenting and psychologically devastating disorder. Childhood-
onset vitiligo has different epidemiological and clinical characteristics as compared to adults …

Background. Vitamin D can play a vital role in autoimmune diseases. Epidemiologic
evidence demonstrates vitamin D deficiency excited in adult patients with vitiligo. Objectives …

The majority of skin conditions are not life-threatening; however, many can be severe and
disfiguring enough to devastate a patient's quality of life. Skin diseases can significantly …

Vitiligo is an autoimmune depigmentation disorder that is estimated to affect about. 5% of the
worldwide population. Half of all cases begin in childhood. A variety of advances occurred in …

Aims: This study was planned to assess the magnitude of childhood onset vitiligo (COV) and
adulthood onset vitiligo (AOV), and compare their clinical pattern. Settings and Design: A …